EGFR and nasopharyngeal carcinoma: Previous research suggests that PI3K/Akt TGF-β/Smad, NF-κB signaling pathways, and EGFR mutations are involved in promoting the growth, proliferation, metastasis, cell cycle, and apoptosis of NPC cells [22–24].